Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 566 results found. Search for [ generic drugs ]

Results 1 to 21 of 566
BusinessToday.In
New Delhi, February 18, 2020
FM Nirmala Sitharaman said the government will soon announce measures to deal with the impact of Coronavirus outbreak on the domestic industry


BusinessToday.In
New Delhi, February 17, 2020
The central government has constituted a Task Force on active pharmaceutical ingredients (APIs) to formulate a road map for the enhanced production of generic drugs in India


BusinessToday.In
New Delhi, February 14, 2020
Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts. An important supplier of generic drugs to the world, Indian companies procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China; The IMF has said that India urgently needs more ambitious structural and financial sector reform measures and a medium-term fiscal consolidation strategy due to the rising debt levels while ensuring a more accommodative fiscal stance in the budget. International Monetary Fund (IMF) spokesperson Gerry Rice said the economic environment in India is weaker than what the organisation had forecast earlier. This and more news on News Blast.Also read: India's wholesale inflation rose to 8-month high of 3.1% in JanuaryAlso read: Page Industries share price falls 8% post Q3 earnings  


BusinessToday.In
New Delhi, February 14, 2020
Urgent need for more ambitious structural, financial sector reforms in India: IMFThe IMF has said that India urgently needs more ambitious structural and financial sector reform measures and a medium-term fiscal consolidation strategy due to the rising debt levels while ensuring a more accommodative fiscal stance in the budget. International Monetary Fund (IMF) spokesperson Gerry Rice said the economic environment in India is weaker than what the organisation had forecast earlier....


Reuters
New Delhi, February 14, 2020
Generic drugmakers say they currently have enough active pharmaceutical ingredients supplies from China to cover their operations for up to about three months


BusinessToday.In
New Delhi, February 12, 2020
The deal comprises a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines


E Kumar Sharma
New Delhi, December 31, 2019
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive


PB Jayakumar
December 19, 2019
Arjun Deshpande's unique pharmacy chain Generic Aadhar sells generic medicines to the masses at much cheaper rates than the market price


PB Jayakumar
December 17, 2019
According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline


E Kumar Sharma
New Delhi, December 10, 2019
Diabetes drug price: Companies are talking of a significant price cut. Intas Pharmaceuticals, according to a senior official in the company, will hit the market today with two versions


PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


PTI
October 25, 2019



Reuters
New Delhi, October 21, 2019
The collateral damage of the United States' trade wars is being felt around the world as President Donald Trump renegotiates relationships with many of Washington's top trading partners.


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


E Kumar Sharma
New Delhi, September 30, 2019
The super rich are pumping enormous amounts of money into research that will extend life - and keep death at bay for a long, long time...


PAGES 1 OF 29  12345